Reported Consolidated quarterly numbers for Brooks Laboratories are:
Net Sales at Rs 17.72 crore in March 2024 up 40.49% from Rs. 12.61 crore in March 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 9.61 crore in March 2024 down 123.47% from Rs. 4.30 crore in March 2023.
EBITDA stands at Rs. 1.04 crore in March 2024 up 1140% from Rs. 0.10 crore in March 2023.
Brooks Labs shares closed at 91.40 on May 17, 2024 (NSE) and has given -28.29% returns over the last 6 months and 44.85% over the last 12 months.
Story continues below Advertisement
| Brooks Laboratories | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Mar'24 | Dec'23 | Mar'23 | | Net Sales/Income from operations | 17.72 | 21.75 | 12.61 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 17.72 | 21.75 | 12.61 | | EXPENDITURE | | Consumption of Raw Materials | 9.74 | 12.09 | 8.34 | | Purchase of Traded Goods | 3.11 | 2.90 | 0.59 | | Increase/Decrease in Stocks | -0.13 | 0.47 | -0.72 | | Power & Fuel | -- | -- | -- | | Employees Cost | 2.28 | 2.84 | 2.26 | | Depreciation | 0.46 | 0.43 | 0.44 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 2.35 | 2.35 | 2.27 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -0.08 | 0.66 | -0.55 | | Other Income | 0.65 | 0.16 | 0.02 | | P/L Before Int., Excpt. Items & Tax | 0.58 | 0.82 | -0.54 | | Interest | 0.27 | 0.21 | 0.18 | | P/L Before Exceptional Items & Tax | 0.30 | 0.60 | -0.72 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 0.30 | 0.60 | -0.72 | | Tax | -- | 0.03 | -- | | P/L After Tax from Ordinary Activities | 0.30 | 0.58 | -0.72 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 0.30 | 0.58 | -0.72 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -9.91 | -4.46 | -3.58 | | Net P/L After M.I & Associates | -9.61 | -3.88 | -4.30 | | Equity Share Capital | 26.25 | 26.25 | 24.70 | | Reserves Excluding Revaluation Reserves | -- | -- | 62.79 | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -3.77 | -1.51 | -1.74 | | Diluted EPS | -3.77 | -1.51 | -1.74 | | EPS After Extra Ordinary | | Basic EPS | -3.77 | -1.51 | -1.74 | | Diluted EPS | -3.77 | -1.51 | -1.74 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
